Analytical Data
-
Gene name
SERTAD4
- Application
-
Alternative Names
DJ667H12.2; SERTA domain containing 4; SERTA domain-containing protein 4; SERTAD4; SRTD4_HUMAN
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NUC0
-
Expression Region
1-356 aa
-
AA Sequence
MTLVLSMNRF CEPIVSEGAA EIAGYQTLWE ADSYGGPSPP GPAQAPLQGD RGAGPPLAGS HYRGISNPIT TSKITYFKRK YVEEEDFHPP LSSCSHKTIS IFEERAHILY MSLEKLKFID DPEVYLRRSV LINNLMKRIH GEIIMQNNWC FPACSFNGTS AQEWFMAQDC PYRKRPRMAK EECEKFHACC FYQECGGHYL NLPLSVNANV GSASTAASSP SASSSSSSSS SSPPLPLPSC SRQVDFDVGS ASIYKSDGQI PANEIFVTNV RSLGVQEKAK LNDEKANDDT NRDGGPLSHE PVGNDLAFEC KGQFYDYFET GYNERNNVNE SWKKSLRKKE ASPPSNKLCC SKGSKI
-
Molecular Weight
39.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SERTAD4, a member of the SERTAD (SERTAD domain-containing) family, has garnered significant attention in recent years due to its potential roles in cellular processes and disease mechanisms. Initially identified as a protein that interacts with several transcription factors and signaling pathways, SERTAD4 has been implicated in crucial biological functions such as cell proliferation, differentiation, and survival. Its expression is particularly notable in the nervous system, suggesting a role in neurodevelopment and neurological disorders. Recent studies have highlighted SERTAD4's involvement in the regulation of various oncogenes and tumor suppressors, thereby positioning it as a potential player in cancer biology. Given the increasing evidence linking SERTAD4 to both neurodevelopmental and oncogenic pathways, researchers are focused on elucidating its molecular mechanisms and potential as a therapeutic target. Recombinant SERTAD4 protein studies provide insights into its biological functions and interactions, facilitating the understanding of its role in health and disease. As we explore the intricate web of SERTAD4's influence on cellular processes, the implications for targeted therapies and biomarker development in cancer and neurological diseases become increasingly relevant.
